A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS.
Amyotroph Lateral Scler Frontotemporal Degener. 2021 May;22(3-4):287-299. doi: 10.1080/21678421.2020.1822410. Epub 2020 Sep 24.
Amyotroph Lateral Scler Frontotemporal Degener. 2021.
PMID: 32969758
Free PMC article.
Clinical Trial.